A 64-year-old Australian man’s late-stage breast cancer diagnosis has renewed attention on a disease many men overlook. Phil Smith sought medical care after his wife noticed blood on his shirt, a small clue that led to a serious finding. Doctors later confirmed stage 3 breast cancer, a diagnosis he says could help other men spot the signs sooner.
Smith, who lives in Australia, shared how a subtle symptom pushed him to act. The case comes as health agencies urge men to pay attention to breast changes, even though the disease is far less common among males. Men make up about 1 percent of breast cancer cases, yet they are often diagnosed later, which can affect outcomes.
“My wife urged me to go to the doctor after noticing bloody spots on my shirt.”
He was ultimately diagnosed with stage 3 breast cancer.
Male Breast Cancer: Rare, But Often Missed
Breast cancer in men is rare compared with women, but it can occur at any age. Risk increases with age, and most cases are found in men over 60. Medical groups say many male tumors are hormone receptor positive, which can respond to drugs like tamoxifen.
Experts point to several risk factors. Family history, especially BRCA2 gene mutations, raises risk. Prior chest radiation, liver disease, Klinefelter syndrome, and obesity are also linked in research. Doctors stress that any new breast lump, skin change, or nipple discharge warrants an exam.
- Nipple discharge, especially bloody or clear
- A firm lump under or near the nipple
- Skin dimpling, scaling, or redness
- Inverted nipple or swelling in the armpit
Because there are no routine screening programs for men in the general population, awareness of symptoms is key. Cancer Australia and international groups advise high-risk men, including those with BRCA mutations or strong family histories, to discuss screening and genetic testing with their doctors.
Why Men Are Diagnosed Later
Clinicians say men often delay seeking help. Some assume breast changes are minor, while others do not realize men can get breast cancer. That delay can allow the cancer to spread to lymph nodes, which defines many stage 3 cases. Later-stage diagnosis usually means more complex treatment and a higher chance of recurrence.
Public health researchers add that stigma and low awareness play a role. Campaigns have focused on women for decades, which has improved survival. Men, by contrast, receive less targeted messaging. Patient advocates argue that simple warnings about nipple discharge and lumps could prompt earlier visits to the clinic.
Treatment Options And Outlook
For many men, treatment begins with surgery. Mastectomy is common due to the smaller amount of breast tissue in males. If lymph nodes are involved, surgeons may remove them to check for spread. Depending on the tumor type, doctors add radiation, chemotherapy, or endocrine therapy.
Most male breast cancers are estrogen receptor positive, so endocrine therapy can lower the chance of the cancer coming back. Adherence to medication is important, since side effects can lead some patients to stop early. Oncologists encourage regular follow-up and discussion of side effects to keep treatment on track.
Outcomes depend on stage at diagnosis and tumor biology. Survival rates improve with early detection and appropriate therapy. Stage 3 disease is serious, but many patients respond well to a combined plan of surgery, radiation, and medication.
Calls For Awareness And Action
Smith’s experience highlights a simple message: notice changes, then see a doctor. Health groups recommend that men at higher risk ask about genetic counseling. Primary care clinics can help with risk assessments and timely referrals to imaging and specialists.
Advocates and clinicians suggest practical steps that could help men:
- Public campaigns that include male symptoms and photos of nipple changes
- Guidance for general practitioners on male presentations
- Clear pathways for genetic testing in high-risk families
- Support groups tailored for men with breast cancer
Researchers are also tracking how male tumors differ from female tumors. Better data can guide tailored treatments. International cancer registries are collecting more information on outcomes, side effects, and adherence in men. This could inform future clinical trials that include male patients more often.
Smith credits his wife for spotting the warning sign. His case is a reminder that small symptoms can signal a larger problem. Early attention may change the course of the disease. Men who notice a lump, discharge, or skin change should make an appointment, not wait. Greater awareness, careful risk assessment, and timely care can improve survival and quality of life for men facing breast cancer.
